A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PTT-121
This is a Phase I, single-center, randomized, double-blind, placebo-controlled SAD/MAD study to evaluate safety, tolerability, and PK of Intravenously Administered PTT-121 in healthy Chinese adults.
Healthy adults aged between 18 and 55 years. [+2]
History of any clinically significant disease or disorder of the cardiovascular,... [+1]